Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy.
about
The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.Evaluating the influence of organ motion during photon vs. proton therapy for locally advanced prostate cancer using biological models.
P2860
Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@en
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@nl
type
label
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@en
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@nl
prefLabel
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@en
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@nl
P2093
P2860
P50
P1476
Urinary bladder dose-response ...... prostate cancer radiotherapy.
@en
P2093
Caroline Olsson
David Alsadius
Jung Hun Oh
Lise Bentzen
Maria Thor
Stine Elleberg Petersen
P2860
P304
P356
10.1016/J.RADONC.2016.01.013
P577
2016-02-12T00:00:00Z